These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives. Pugsley MK; Yong SL; Goldin AL; Hayes ES; Walker MJA Eur J Pharmacol; 2019 Feb; 844():241-252. PubMed ID: 30571955 [TBL] [Abstract][Full Text] [Related]
43. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias]. Ravens U Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288 [TBL] [Abstract][Full Text] [Related]
44. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat. Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491 [TBL] [Abstract][Full Text] [Related]
45. Investigational antiarrhythmic agents: promising drugs in early clinical development. Heijman J; Ghezelbash S; Dobrev D Expert Opin Investig Drugs; 2017 Aug; 26(8):897-907. PubMed ID: 28691539 [TBL] [Abstract][Full Text] [Related]
47. New directions in the development of antiarrhythmic drugs. Miura DS; Rosen MR J Clin Pharmacol; 1984 Jul; 24(7):333-41. PubMed ID: 6090508 [TBL] [Abstract][Full Text] [Related]
48. Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past--perspectives of the future. Varro A; Nanasi PP; Acsai K; Virag L; Papp JG Curr Pharm Des; 2004; 10(20):2411-27. PubMed ID: 15320753 [TBL] [Abstract][Full Text] [Related]
55. Antiarrhythmics--from cell to clinic: past, present, and future. Hancox JC; Patel KC; Jones JV Heart; 2000 Jul; 84(1):14-24. PubMed ID: 10862579 [No Abstract] [Full Text] [Related]
56. Newer antiarrhythmic drugs. Michelson EL; Dreifus LS Med Clin North Am; 1988 Mar; 72(2):275-319. PubMed ID: 3279283 [TBL] [Abstract][Full Text] [Related]
57. Arctigenin, a potential anti-arrhythmic agent, inhibits aconitine-induced arrhythmia by regulating multi-ion channels. Zhao Z; Yin Y; Wu H; Jiang M; Lou J; Bai G; Luo G Cell Physiol Biochem; 2013; 32(5):1342-53. PubMed ID: 24280730 [TBL] [Abstract][Full Text] [Related]
58. Preventing unfolded protein response-induced ion channel dysregulation to treat arrhythmias. Liu M; Kang GJ; Dudley SC Trends Mol Med; 2022 Jun; 28(6):443-451. PubMed ID: 35414478 [TBL] [Abstract][Full Text] [Related]
59. New advances in class III antiarrhythmic drug therapy. Sager PT Curr Opin Cardiol; 1999 Jan; 14(1):15-23. PubMed ID: 9932203 [TBL] [Abstract][Full Text] [Related]
60. Arrhythmia models for drug research: classification of antiarrhythmic drugs. Hashimoto K J Pharmacol Sci; 2007 Apr; 103(4):333-46. PubMed ID: 17409630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]